Allovir Historical Financial Ratios
| ALVR Stock | USD 0.45 0.01 2.17% |
Allovir is presently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.51 or Days Sales Outstanding of 1.2 K will help investors to properly organize and evaluate Allovir financial condition quickly.
Allovir |
About Allovir Financial Ratios Analysis
AllovirFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Allovir investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Allovir financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Allovir history.
Allovir Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Allovir stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Allovir sales, a figure that is much harder to manipulate than other Allovir multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Allovir's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Allovir current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allovir. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Allovir Stock, please use our How to Invest in Allovir guide.At this time, Allovir's Interest Debt Per Share is relatively stable compared to the past year. As of 12/15/2024, Price Book Value Ratio is likely to grow to 0.51, while Operating Cash Flow Per Share is likely to drop (1.26).
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 6.69 | 9.99 | 6.61 | 6.28 | Net Debt To EBITDA | 1.01 | 0.42 | 0.33 | 0.31 |
Allovir fundamentals Correlations
Click cells to compare fundamentals
Allovir Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Allovir fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | (32.1) | 2.93 | 3.61 | 1.75 | 0.49 | 0.51 | |
| Book Value Per Share | (0.79) | 13.13 | 3.59 | 2.93 | 1.4 | 2.59 | |
| Free Cash Flow Yield | (0.0124) | (0.059) | (0.13) | (0.36) | (1.76) | (1.67) | |
| Operating Cash Flow Per Share | (0.31) | (2.26) | (1.69) | (1.85) | (1.2) | (1.26) | |
| Pb Ratio | (32.1) | 2.93 | 3.61 | 1.75 | 0.49 | 0.51 | |
| Free Cash Flow Per Share | (0.31) | (2.27) | (1.69) | (1.85) | (1.2) | (1.26) | |
| Roic | 0.47 | (0.19) | (0.67) | (0.66) | (1.05) | (0.99) | |
| Net Income Per Share | (0.33) | (2.54) | (2.74) | (2.2) | (1.83) | (1.92) | |
| Cash Per Share | 1.94 | 13.25 | 3.95 | 3.05 | 1.77 | 1.68 | |
| Pocfratio | (82.02) | (17.0) | (7.64) | (2.77) | (0.57) | (0.54) | |
| Pfcf Ratio | (80.66) | (16.94) | (7.64) | (2.77) | (0.57) | (0.54) | |
| Income Quality | 0.85 | 0.87 | 0.62 | 0.84 | 0.65 | 0.41 | |
| Roe | 0.42 | (0.19) | (0.76) | (0.75) | (1.31) | (1.24) | |
| Ev To Operating Cash Flow | (79.57) | (15.13) | (6.03) | (2.27) | (0.0647) | (0.0614) | |
| Pe Ratio | (75.92) | (15.12) | (4.72) | (2.33) | (0.37) | (0.39) | |
| Return On Tangible Assets | (0.16) | (0.18) | (0.6) | (0.61) | (1.0) | (0.95) | |
| Ev To Free Cash Flow | (78.25) | (15.07) | (6.03) | (2.27) | (0.0647) | (0.0614) | |
| Earnings Yield | (0.0132) | (0.0661) | (0.21) | (0.43) | (2.69) | (2.56) | |
| Net Debt To E B I T D A | 1.85 | 1.63 | 1.01 | 0.42 | 0.33 | 0.31 | |
| Current Ratio | 13.98 | 29.39 | 6.69 | 9.99 | 6.61 | 6.28 | |
| Tangible Book Value Per Share | (0.79) | 13.13 | 3.59 | 2.93 | 1.4 | 2.59 | |
| Graham Number | 2.44 | 27.4 | 14.87 | 12.04 | 7.59 | 8.73 | |
| Shareholders Equity Per Share | (0.79) | 13.13 | 3.59 | 2.93 | 1.4 | 2.59 | |
| Graham Net Net | (0.99) | 12.59 | 2.98 | 2.36 | 1.34 | 2.32 | |
| Enterprise Value Over E B I T D A | (60.11) | (13.2) | (3.77) | (1.94) | (0.0423) | (0.0444) | |
| Price Earnings Ratio | (75.92) | (15.12) | (4.72) | (2.33) | (0.37) | (0.39) | |
| Price Book Value Ratio | (32.1) | 2.93 | 3.61 | 1.75 | 0.49 | 0.51 | |
| Price To Operating Cash Flows Ratio | (82.02) | (17.0) | (7.64) | (2.77) | (0.57) | (0.54) | |
| Price To Free Cash Flows Ratio | (80.66) | (16.94) | (7.64) | (2.77) | (0.57) | (0.54) | |
| Ebt Per Ebit | 0.89 | 0.98 | 1.01 | 0.99 | 1.05 | 0.74 |
Pair Trading with Allovir
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allovir position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will appreciate offsetting losses from the drop in the long position's value.Moving together with Allovir Stock
Moving against Allovir Stock
| 0.78 | DYAI | Dyadic International | PairCorr |
| 0.67 | ESPR | Esperion Therapeutics | PairCorr |
| 0.63 | BMY | Bristol Myers Squibb | PairCorr |
| 0.45 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
| 0.36 | DNA | Ginkgo Bioworks Holdings | PairCorr |
The ability to find closely correlated positions to Allovir could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allovir when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allovir - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allovir to buy it.
The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allovir moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allovir moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allovir can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Allovir Stock Analysis
When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.